OPHTANEO TECHNOLOGIE : revenue, balance sheet and financial ratios

OPHTANEO TECHNOLOGIE is a French company founded 9 years ago, specialized in the sector Commerce de gros (commerce interentreprises) de produits pharmaceutiques. Based in LA CIOTAT (13600), this company of category PME shows in 2022 a revenue of 2.5 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-09

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - OPHTANEO TECHNOLOGIE (SIREN 823813225)
Indicator 2024 2023 2022 2021 2020 2018
Revenue N/C N/C 2 508 666 € N/C N/C 861 436 €
Net income 278 973 € 452 910 € 244 725 € 224 528 € 107 611 € 44 490 €
EBITDA N/C N/C 416 537 € N/C N/C 65 279 €
Net margin N/C N/C 9.8% N/C N/C 5.2%

Revenue and income statement

In 2024, OPHTANEO TECHNOLOGIE generates positive net income of 279 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2018-2024: 44 k€ -> 279 k€.

Net income (2024) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

278 973 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 43%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 54%. This high autonomy means the company finances most of its assets through equity, a sign of strength.

Debt ratio (2024) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

43.142%

Financial autonomy (2024) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

54.496%

Asset age ratio (2024) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

42.1%

Solvency indicators evolution
OPHTANEO TECHNOLOGIE

Sector positioning

Debt ratio
43.14 2024
2022
2023
2024
Q1: 0.0
Med: 4.27
Q3: 43.96
Average +16 pts over 3 years

In 2024, the debt ratio of OPHTANEO TECHNOLOGIE (43.14) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.

Financial autonomy
54.5% 2024
2022
2023
2024
Q1: 14.64%
Med: 38.36%
Q3: 60.56%
Good

In 2024, the financial autonomy of OPHTANEO TECHNOLOGIE (54.5%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.

Repayment capacity
0.26 years 2022
2022
Q1: 0.0 years
Med: 0.01 years
Q3: 1.6 years
Average

In 2022, the repayment capacity of OPHTANEO TECHNOLOGIE (0.26) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 358.79. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2024) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

358.789

Liquidity indicators evolution
OPHTANEO TECHNOLOGIE

Sector positioning

Liquidity ratio
358.79 2024
2022
2023
2024
Q1: 132.74
Med: 202.27
Q3: 325.9
Excellent +23 pts over 3 years

In 2024, the liquidity ratio of OPHTANEO TECHNOLOGIE (358.79) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.

Interest coverage
0.3x 2022
2022
Q1: 0.0x
Med: 0.34x
Q3: 4.26x
Average

In 2022, the interest coverage of OPHTANEO TECHNOLOGIE (0.3x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.

Operating WCR (2024) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

0 €

Customer credit (2024) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

0 j

Supplier credit (2024) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

0 j

Inventory turnover (2024) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

0 j

WCR and payment terms evolution
OPHTANEO TECHNOLOGIE

Positioning of OPHTANEO TECHNOLOGIE in its sector

Comparison with sector Commerce de gros (commerce interentreprises) de produits pharmaceutiques

Valuation estimate

Based on 124 transactions of similar company sales (all years), the value of OPHTANEO TECHNOLOGIE is estimated at 229 180 € (range 87 227€ - 836 938€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2024
124 transactions
87k€ 229k€ 836k€
229 180 € Range: 87 227€ - 836 938€
NAF 5 all-time

Valuation method used

Net Income Multiple
278 973 € × 0.8x = 229 181 €
Range: 87 228€ - 836 939€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 124 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de gros (commerce interentreprises) de produits pharmaceutiques)

Compare OPHTANEO TECHNOLOGIE with other companies in the same sector:

Frequently asked questions about OPHTANEO TECHNOLOGIE

What is the revenue of OPHTANEO TECHNOLOGIE ?

The revenue of OPHTANEO TECHNOLOGIE in 2022 is 2.5 M€.

Is OPHTANEO TECHNOLOGIE profitable?

Yes, OPHTANEO TECHNOLOGIE generated a net profit of 279 k€ in 2024.

Where is the headquarters of OPHTANEO TECHNOLOGIE ?

The headquarters of OPHTANEO TECHNOLOGIE is located in LA CIOTAT (13600), in the department Bouches-du-Rhone.

Where to find the tax return of OPHTANEO TECHNOLOGIE ?

The tax return of OPHTANEO TECHNOLOGIE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does OPHTANEO TECHNOLOGIE operate?

OPHTANEO TECHNOLOGIE operates in the sector Commerce de gros (commerce interentreprises) de produits pharmaceutiques (NAF code 46.46Z). See the 'Sector positioning' section above to compare the company with its competitors.